Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Rehabilitation program for allogeneic bone marrow transplant patients

Official title: A Type 1 Hybrid Effectiveness Implementation Trial of a Longitudinal Multidimensional Rehabilitation Program for Patients Undergoing Allogeneic Blood and Marrow Transplantation (CaRE4alloBMT)

Run by University Health Network, Toronto · NCT07457866 · Data updated 2026-11-12

This trial will test whether the CaRE-4-alloBMT rehab program helps adults having allogeneic bone marrow transplants recover better than usual care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment208 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedJune 30, 2028
Study endsAugust 30, 2028
Registry record updatedMarch 9, 2026
Trial IDNCT07457866 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age >18) scheduled for allogeneic bone marrow transplant for a hematologic cancer who complete pre- and post-transplant care at Princess Margaret Cancer Centre, can access online study material, and understand English.

Probably not a fit

Patients who have comorbidities or musculoskeletal issues that preclude exercise, cannot access online materials, are being admitted for transplant within two weeks of assessment, or are enrolled in other interventional studies may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pragmatic, two-arm randomized controlled trial comparing the CaRE-4-alloBMT rehabilitation program to usual care in adults undergoing allogeneic bone marrow transplant. Participants complete questionnaires and an initial assessment with a registered kinesiologist, then are randomized to the intervention or usual care. Outcomes include patient-reported measures and physiological assessments collected at baseline, hospital admission, discharge, and at 3 and 6 months post-discharge to capture real-world recovery. The trial emphasizes external validity to inform whether the program can be delivered in routine clinical practice.

Why it matters

Potential benefit: If successful, the program could speed physical recovery, improve quality of life, and reduce post-transplant complications for alloBMT patients.

How similar studies have gone: Exercise and prehabilitation programs in cancer populations have shown benefits for physical function and recovery, but robust phase‑III evidence specifically for allogeneic BMT patients is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• scheduled to undergo alloBMT and are:

* \> 18 years of age;
* receiving treatment for a hematologic cancer;
* completing pre- and post-transplant care at PM;
* able to access on-line study material; and
* able to understand (spoken and written) English. Participants receiving a second transplant at the time of screening will be included if they meet the above criteria.

Exclusion Criteria:

* scheduled to be admitted to the hospital for their alloBMT \< 2 weeks from the initial assessment booking, as this will not allow enough time for the prehabilitation phase of the study;
* are participating in any other clinical trials or supportive care intervention studies; or
* have comorbidities or musculoskeletal complications that preclude participation in the exercise programs.

Where it's running

  • Princess Margaret Cancer Centre
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Jennifer M Jones, PhD — UHN Princess Margaret Cancer Centre
  • Study coordinator: Jennifer M Jones, PhD
  • Email: Jennifer.jones@uhn.ca
  • Phone: 14165818603

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.